Clincosm LogoSign in Get a demo

Improvement of Hyperglycemia/Diabetes in Patients to Improve Safety

Sponsor
Northwestern University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06096311
Collaborator
(none)
30
Enrollment
1
Location
32
Anticipated Duration (Months)
0.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The goal of this project is to bring together staff and clinicians from Northwestern University/Northwestern Medical Group/Northwestern Memorial Hospital as well as patients and caregivers to assess and redesign the identification and management of hyperglycemia and diabetes during and in transitions of care. There will be 3 different groups for the study: a group of providers [Group 1], a group of patients/caregivers and laypersons [Group 2], and a stakeholder group [Group 3]. Participants will be asked to provide input on potential interventions for a future clinical trial.

Condition or Disease Intervention/Treatment Phase
  • Other: Interviews

Study Design

Study Type:
Observational
Anticipated Enrollment :
30 participants
Observational Model:
Ecologic or Community
Time Perspective:
Prospective
Official Title:
Improvement of Hyperglycemia/Diabetes in Patients to Improve Safety
Actual Study Start Date :
Apr 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Outcome Measures

Primary Outcome Measures

  1. Qualitative Results from Interviews [Up to one year]

    Participants will be asked to provide their thoughts on potential interventions for a future clinical trial.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

  • Provider Group: Multidisciplinary clinical team (including but not limited to inpatient endocrine nurse practitioners, nurse coordinators, diabetes educators, outpatient nurses, attending physicians, and pharmacists)

  • Patient, Caregiver and Layperson Group: Patients must have had hyperglycemia or diabetes at Northwestern Memorial Hospital in the last 5 years.

  • Stakeholder Group: Involved in the specific care delivery of diabetes

Exclusion Criteria:

  • Provider Group: None

  • Patient, Caregiver, and Layperson Group: Patients will be excluded if they did not have diabetes or had hyperglycemia.

  • Stakeholder Group: None

Contacts and Locations

Locations

Site City State Country Postal Code
1 Northwestern University Chicago Illinois United States 60611

Sponsors and Collaborators

  • Northwestern University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Amisha Wallia, Associate Professor, Northwestern University
ClinicalTrials.gov Identifier:
NCT06096311
Other Study ID Numbers:
  • STU00090319
First Posted:
Oct 23, 2023
Last Update Posted:
Oct 23, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Hyperglycemia

Study Results

No Results Posted as of Oct 23, 2023